Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

1.86
Delayed Data
As of Dec 05
 +0.06 / +3.33%
Today’s Change
1.22
Today|||52-Week Range
2.76
-5.55%
Year-to-Date
SECTOR
--
INDUSTRY
--
MARKET CAP
--

Company Description

Novelion Therapeutics, Inc. develops and markets ocular products. The company is headquartered in Vancouver, Canada.

Contact Information

Novelion Therapeutics, Inc.
887 Great Northern Way
Vancouver British Columbia V5T 4T5
P:(877) 764-3131
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Mary J. SzelaChief Executive Officer
Gregory D. PerryChief Financial & Administrative Officer